Pfizer nears deal with US government to supply additional Covid-19 vaccine doses
[BENGALURU] Pfizer Inc is close to striking a deal with the US government to supply at least tens of millions of additional doses of its Covid-19 vaccine candidate next year in exchange for a government directive giving it better access to manufacturing supplies, the New York Times reported on Tuesday.
An agreement could be announced as early as Wednesday, the newspaper reported, citing people familiar with the discussions.
Pfizer did not immediately respond to a Reuters request for comment.
Pfizer and partner BioNTech SE as well as rival Moderna Inc recently won the US emergency use authorization for their respective vaccine candidates.
The US government has signed a deal with Pfizer for 100 million doses of its vaccine, which has started being rolled out across the country.
The government is asking for 100 million additional doses from Pfizer from April through June, according to the NYT report.
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
In exchange, the deal calls for the government to invoke the Defence Production Act to give Pfizer better access to roughly nine specialised products it needs to make the vaccine, the report said.
REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
US chip workers are likely to quit jobs, worsening labour shortage
India's industrial output up 4.9% year-on-year in March
Pandemic treaty talks end without agreed text, next step up for debate
Canada job gains blow past forecasts; wage growth slows
ECB set scene for June rate cut at last meeting, account shows
Japan closely monitoring weak yen, PM Kishida says, in fresh warning from Tokyo